Jennifer Creel
Keine laufenden Positionen mehr
Profil
Jennifer Creel worked as Vice President-Global Finance & Business Planning at Celgene Corp.
from 2008 to 2020.
She then worked as Chief Financial Officer at ADC Therapeutics SA from 2020 to 2022.
Ms. Creel received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Ehemalige bekannte Positionen von Jennifer Creel
Unternehmen | Position | Ende |
---|---|---|
ADC THERAPEUTICS SA | Director of Finance/CFO | 19.12.2022 |
CELGENE | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Jennifer Creel
The College of William & Mary | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
Private Unternehmen | 1 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |